New hope for advanced cancer: first human trial of ASD141 begins
Disease control
Recruiting now
This early-stage study tests a new drug called ASD141 in 21 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants will receive the drug an…
Phase: PHASE1 • Sponsor: Ascendo Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC